Drug approval is unequivocally the linchpin to any drug development effort and, given the role of the US market in the global marketplace, the drug approval standard employed by FDA remains a ...
On April 18, U.S. Food and Drug Administration (FDA) Commissioner Marty Makary announced plans to roll-out a new approval pathway for rare disease drugs. Commissioner Makary’s comments build on ...
Forbes contributors publish independent expert analyses and insights. Greg Licholai writes and teaches about innovation in healthcare. In a move that could dramatically reshape the landscape for rare ...
Circle receives OCC approval to form a U.S. National Trust Bank, integrating USDC with federal oversight and institutional ...
Conditional non-FTA authorizations have returned under the second Trump administration as the United States continues to be an exporter of LNG to the rest of the world. Over the past two decades, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback